Adcock Ingram Limited Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Adcock Ingram Limited Pharmaceutical Import Records from India — 8 Products, $77.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Adcock Ingram Limited — Pharmaceutical Importer Profile (2026) | 8 Products, $77.5M Trade | TransData Nexus

Adcock Ingram Limited

Pharmaceutical Importer · South Africa · Analgesics & Antipyretics Focus · $77.5M Total Trade · DGFT Verified

Adcock Ingram Limited is a pharmaceutical importer based in South Africa with a total trade value of $77.5M across 8 products in 5 therapeutic categories. Based on 3,265 verified import shipments from Indian Customs (DGFT) records, Adcock Ingram Limited is the #1 buyer in 2 products including Paracetamol, Caffeine. Adcock Ingram Limited sources from 5 verified Indian suppliers, with Adcock Ingram Limited accounting for 94.0% of imports.

Adcock Ingram Limited — Import Portfolio & Supplier Network

Adcock Ingram Limited import network — 8 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Adcock Ingram Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Adcock Ingram Limited	$72.6M	4,380	94.0%
Adcock Ingram Pharma Private Limited	$4.1M	155	5.3%
Medreich Limited	$386.8K	15

What Formulations Does Adcock Ingram Limited Import?

Formulation	Value	Ships
Adcodol tablets (paracetamol	$3.6M	90
Panado tablets (paracetamol 500MG	$2.2M	154
Adco-napamol tablets (paracetamol 500MG	$2.1M	115
Scopex 10MG tablets (hyoscine butyl	$1.4M	27
Genpayne capsules (paracetamol	$1.2M	46
Allergex 4MG tablets (chlorpheniramine	$1.1M	101
Compral pain tablets (paracetamol	$907.6K	53
Adco-napamol tablets(paracetamol 500MG	$769.5K	44
Spasmend tablets (paracetamol	$708.7K	52
Adco dol tablets(paracetamol	$631.3K	19
Synaleve capsules (paracetamol	$601.0K	13
Betapyn tablets (paracetamol	$591.4K	37
Mypaid capsules (paracetamol	$539.8K	22
Compral pain tablets paracetamol	$510.4K	31
Scopex 10MG tablets hyoscine butyl	$500.0K	10

Adcock Ingram Limited imports 2,247 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 8 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Codeine	Analgesics & Antipyretics	$28.4M	855	26.0%	2
2	Paracetamol	Analgesics & Antipyretics	$23.8M	1,040	5.7%	1
3	Caffeine	Respiratory & OTC	$18.7M	698	17.4%	1
4	Chlorpheniramine	Antihistamines & Allergy	$2.8M	312	3.9%	3
5	Aspirin	Analgesics & Antipyretics	$2.3M	161	6.1%	3
6	Atenolol	Cardiovascular	$653.8K	74	1.6%	15
7	Metoclopramide	Gastrointestinal	$509.6K	101	1.2%	7
8	Bisacodyl	Gastrointestinal	$222.6K	24	1.6%	9

Adcock Ingram Limited imports 8 pharmaceutical products across 5 categories into South Africa totaling $77.5M. The company is the #1 buyer for 2 products: Paracetamol, Caffeine.

Adcock Ingram Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Adcock Ingram Limited is a prominent South African pharmaceutical company specializing in the manufacture, marketing, and distribution of a diverse range of healthcare products. Established in 1890, the company has a longstanding presence in the industry, serving both private and public sectors across Southern Africa and India. Its product portfolio encompasses consumer goods, over-the-counter (OTC) medications, prescription drugs, and hospital products and services. Therapeutic areas addressed by Adcock Ingram include hypertension, diabetes, pain management, respiratory conditions, and women's health, among others.

Headquartered in Midrand, South Africa, Adcock Ingram Holdings Limited is listed on the Johannesburg Stock Exchange under the ticker symbol AIP. The company operates through four main segments: Consumer, OTC, Prescription, and Hospital Products and Services. In 2024, Adcock Ingram reported revenues of R9.6 billion, with an operating income of R1.1 billion and a net income of R814 million.

2Distribution Network

Adcock Ingram Limited boasts an extensive distribution network within South Africa, ensuring widespread availability of its products. The company operates multiple warehouses strategically located to facilitate efficient logistics and timely delivery to various regions. While specific warehouse locations are not publicly disclosed, Adcock Ingram's infrastructure supports its comprehensive distribution capabilities, catering to both urban and rural areas across the country. Additionally, the company has expanded its reach to select emerging markets, including India, through subsidiaries such as Adcock Ingram Pharma Private Limited, established in 2021.

3Industry Role

In South Africa's pharmaceutical supply chain, Adcock Ingram Limited functions primarily as a manufacturer and distributor. The company produces a wide array of branded and generic medicines, including treatments for various conditions such as pain relief, respiratory issues, dermatological conditions, women's health, and cardiovascular diseases. Adcock Ingram also has a significant presence in the critical care market, serving as a major supplier of hospital and critical care products.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Adcock Ingram Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Adcock Ingram Limited's sourcing strategy exhibits a high degree of concentration, particularly in its imports from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations valued at $77.5 million USD from India, encompassing 3,265 shipments across 8 products in 5 therapeutic categories. The top five imported products—Paracetamol, Caffeine, Codeine, Chlorpheniramine, and Aspirin—accounted for 98.2% of the total import value. This concentration indicates a strategic focus on specific high-demand products, potentially leveraging favorable pricing and supply chain efficiencies. However, such dependency on a limited number of suppliers may pose risks related to supply chain disruptions or regulatory changes affecting these products.

2Supply Chain Resilience

Adcock Ingram Limited's supply chain resilience is closely tied to its sourcing practices from India. The company's reliance on a select group of suppliers, including its own subsidiaries like Adcock Ingram Pharma Private Limited, suggests a controlled supply chain with potentially streamlined operations. However, the limited number of suppliers may expose the company to risks such as supply disruptions or regulatory changes affecting these suppliers. The diversity of formulations imported, with 2,247 unique formulations, indicates a broad product range, which can mitigate risks associated with over-reliance on a single product or supplier. Ensuring compliance with international quality standards and maintaining robust relationships with suppliers are crucial for sustaining supply chain resilience.

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

In South Africa, the primary regulatory authority overseeing pharmaceutical imports is the South African Health Products Regulatory Authority (SAHPRA). SAHPRA is responsible for ensuring the safety, efficacy, and quality of health products, including medicines, medical devices, and related substances. Key legislation governing pharmaceutical imports includes the Medicines and Related Substances Act, which outlines the requirements for the registration, importation, and distribution of medicines. The marketing authorization pathway for Indian generics involves obtaining registration from SAHPRA, which requires submission of comprehensive data demonstrating the product's quality, safety, and efficacy.

2Import Licensing & GMP

Import licensing requirements in South Africa stipulate that all medicines imported into the country must be registered with SAHPRA. Manufacturers and suppliers must provide evidence of Good Manufacturing Practice (GMP) compliance, typically through certificates such as EU GMP, WHO GMP, or PIC/S. These certifications ensure that the manufacturing processes meet international standards for quality and safety. Additionally, wholesale distribution authorization is required for entities involved in the distribution of medicines, ensuring that they operate in compliance with regulatory standards.

Adcock Ingram Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Adcock Ingram Limited's product category focus on Analgesics & Antipyretics (70.4%), Respiratory & OTC (24.2%), and Antihistamines & Allergy (3.7%) aligns with prevalent health concerns in South Africa. The high demand for pain relief and fever-reducing medications, as well as respiratory treatments, drives the importation of these products. The company's strategic emphasis on these therapeutic areas allows it to address significant market needs and maintain a competitive edge in the pharmaceutical sector.

2Sourcing Profile

Adcock Ingram Limited's sourcing strategy is centered on importing generic drugs from India, focusing on finished pharmaceutical formulations. The company's preference for specific formulations, such as Paracetamol and Caffeine, indicates a targeted approach to meet market demand. India's established pharmaceutical manufacturing capabilities and cost advantages make it a strategic partner for Adcock Ingram, enabling the company to offer a diverse range of high-quality products to the South African market.

3Market Positioning

Based on its product mix, Adcock Ingram Limited serves multiple segments of the South African market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. The company's comprehensive portfolio allows it to cater to a wide range of healthcare needs, positioning it as a versatile and significant player in the pharmaceutical industry.

Seller's Guide — How to Become a Supplier to Adcock Ingram Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Adcock Ingram Limited, particularly in the therapeutic areas where the company has a strong focus. Gaps in Adcock Ingram's current sourcing may exist in specialized formulations or emerging treatments not currently covered. Indian exporters can explore these opportunities by offering innovative products that align with Adcock Ingram's strategic objectives and market demands.

2Requirements & Qualifications

Indian exporters aiming to supply Adcock Ingram Limited and the South African market must ensure compliance with SAHPRA's registration requirements, including providing evidence of GMP certification from recognized authorities such as the EU, WHO, or PIC/S. Products must meet South African quality standards, and labeling must adhere to regulatory guidelines, including language requirements and necessary product information. Additionally, exporters should be prepared to undergo audits and inspections to verify compliance with import and distribution regulations.

3How to Approach

Frequently Asked Questions — Adcock Ingram Limited

What products does Adcock Ingram Limited import from India?

Adcock Ingram Limited imports 8 pharmaceutical products across 5 categories. Top imports: Codeine ($28.4M), Paracetamol ($23.8M), Caffeine ($18.7M), Chlorpheniramine ($2.8M), Aspirin ($2.3M).

Who supplies pharmaceuticals to Adcock Ingram Limited from India?

Adcock Ingram Limited sources from 5 verified Indian suppliers. The primary supplier is Adcock Ingram Limited (94.0% of imports, $72.6M).

What is Adcock Ingram Limited's total pharmaceutical import value?

Adcock Ingram Limited's total pharmaceutical import value from India is $77.5M, based on 3,265 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Adcock Ingram Limited focus on?

Adcock Ingram Limited imports across 5 categories. The largest: Analgesics & Antipyretics (70.4%), Respiratory & OTC (24.2%), Antihistamines & Allergy (3.7%).

Get Full Adcock Ingram Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.